ACCELERON PHARMA INC. Current Liabilities
ACCELERON PHARMA INC. had Current Liabilities of $57.37 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2021-11-04
- 2021-09-30: Liabilities, Current $57.37M.
- 2021-06-30: Liabilities, Current $59.48M.
- 2021-03-31: Liabilities, Current $49.82M.
- 2020-12-31: Liabilities, Current $60.16M.
| Period end | Liabilities, Current |
|---|---|
| 2021-09-30 | $57.37M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $59.48M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $49.82M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $60.16M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $37.30M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $37.36M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $28.53M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $33.37M 10-K · filed 2021-02-25 |
| 2019-09-30 | $31.64M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $26.06M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $23.27M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $18.91M 10-K · filed 2020-02-27 |
| 2018-09-30 | $14.68M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $14.57M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $12.94M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $16.75M 10-K · filed 2019-02-27 |
| 2017-09-30 | $15.88M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $14.30M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $15.19M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $16.15M 10-K · filed 2018-02-27 |
| 2016-09-30 | $16.19M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $13.69M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $15.18M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $14.49M 10-K · filed 2017-03-01 |
| 2015-09-30 | $12.87M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $11.44M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $9.78M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $9.25M 10-K · filed 2016-02-25 |
| 2014-09-30 | $11.11M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $16.09M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $9.19M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $27.21M 10-K · filed 2015-03-02 |
| 2013-09-30 | $16.52M 10-Q · filed 2013-11-14 |
| 2012-12-31 | $38.80M 10-K · filed 2014-03-17 |